Results 21 to 30 of about 37,328 (240)

Malignant hyperthermia (literature review)

Вестник анестезиологии и реаниматологии, 2023
The objective – to summarize the current literature data on the etiology, pathogenesis, diagnosis and treatment of malignant hyperthermia.   The search and analysis of literature data on malignant hyperthermia in the medical information systems PubMed ...
R. R. Tukhvatullina, N. V. Matinyan
doaj   +1 more source

Skeletal muscle microalterations in patients carrying Malignant Hyperthermia-related mutations of the e-c coupling machinery

European Journal of Translational Myology, 2016
We have compared the ultrastructure of skeletal muscle biopsies from patients that have survived a [Malignant Hyperthermia, MH] episode and siblings that test positive for MH susceptibility with those from siblings that tested negatives.
Manuela Lavorato, Pawan K. Gupta, Philip M. Hopkins, Clara Franzini-Armstrong   +3 more
doaj   +1 more source

Malignant hyperthermia: A case report

Human Pathology Reports, 2023
Malignant hyperthermia is a rare hypermetabolic pharmacogenetic pathologic disorder of calcium release control in skeletal muscle following exposure to depolarizing muscle relaxants and inhalational anesthetics in general anesthesia.
Fereshteh Amiri, Mahbobeh Rashidi, Mohsen Savaei   +2 more
doaj   +1 more source

Variants in ASPH cause exertional heat illness and are associated with malignant hyperthermia susceptibility

Nature Communications, 2022
The genetic cause(s) of malignant hyperthermia and exertional heat illness are unknown in approximately 30% of cases. To address this barrier, the authors performed genome sequencing on a large cohort of cases, identifying rare variants in ASPH, a gene ...
Yukari Endo, Linda Groom, Alper Celik, Natalia Kraeva, Chang Seok Lee, Sung Yun Jung, Lois Gardner, Marie-Anne Shaw, Susan L. Hamilton, Philip M. Hopkins, Robert T. Dirksen, Sheila Riazi, James J. Dowling   +12 more
doaj   +1 more source

Malignant hyperthermia—or not? [PDF]

Anaesthesia, 1985
SummarySome of the problems of diagnosis and management of malignant hyperthermia are discussed as illustrated by three case reports.
openaire   +3 more sources

Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells

International Journal of Hyperthermia, 2023
Cellular metabolic reprogramming is an important feature of malignant tumors. Metabolic reprogramming causes changes in the levels or types of specific metabolites inside and outside the cell, which affects tumorigenesis and progression by influencing ...
Yuchuan Yang, Linkuan Huangfu, Huizhen Li, Daoke Yang   +3 more
doaj   +1 more source

Malignant Hyperthermia Like Manifestations during Management of Refractory Status Epilepticus

Journal of Neuroanaesthesiology and Critical Care, 2023
Management of refractory status epilepticus is challenging for a neurointensivist consequent to systemic complexities associated with various drugs and modalities involved in its treatment.
Deepti Srinivas, Venkatesh Keshavan, Vikram Kamath, Manju Manmadhan   +3 more
doaj   +1 more source

Anesthesia for muscle biopsy to test susceptibility to malignant hyperthermia [PDF]

Revista Brasileira de Anestesiologia, 2019
Introduction Malignant hyperthermia is an autosomal dominant pharmacogenetic disorder, characterized by hypermetabolic crisis triggered by halogenated anesthetics and/or succinylcholine.
Helga Cristina Almeida da Silva, Elton Shinji Onari, Isac de Castro, Marcelo Vaz Perez, Alexandre Hortensi, José Luiz Gomes do Amaral   +5 more
doaj   +3 more sources

Postoperative Malignant Hyperthermia-A Medical Emergency: A Case Report and Review of Literature [PDF]

Journal of Clinical and Diagnostic Research, 2017
Malignant hyperthermia is a rare life threatening pharmacological disorder. Preoperative clinical diagnosis is not possible. Due to its rarity and severity, it must be taken as an important differential diagnosis for postoperative hyperthermia.
Amit Kumar Sinha, Poonam Kumari, Maheshkumar Manilal Vaghela, Chandni Sinha, Bindey Kumar   +4 more
doaj   +1 more source

Isoflurane Induced Malignant Hyperthermia in a Patient with Glucose 6-Phosphate Dehydrogenase Deficiency and Growth Hormone Abuse

Case Reports in Anesthesiology, 2020
Malignant hyperthermia is a pharmacogenetic disorder in the regulation of calcium in skeletal muscles which is related to an uninhibited muscle hypermetabolic reaction to potent inhalation agents, the depolarizing muscle relaxant succinylcholine, and to ...
Hojatolah Ravaei, Mohammad Javad Yavari Barhaghtalab, Vahid Salehi, Hossein Hejr   +3 more
doaj   +1 more source